Drug Profile


Alternative Names: F 98214 TA; flufenoxina

Latest Information Update: 19 Jan 2012

Price : $50

At a glance

  • Originator FAES Farma
  • Developer FAES Farma; Jazz Pharmaceuticals
  • Class Antidepressants
  • Mechanism of Action Adrenergic receptor antagonists; Dopamine uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Major depressive disorder

Most Recent Events

  • 18 Jan 2012 Azur Pharma has merged with Jazz Pharmaceuticals Inc to form Jazz Pharmaceuticals plc
  • 20 Aug 2010 Discontinued - Preclinical for Depression in USA (unspecified route)
  • 20 Aug 2010 Discontinued - Preclinical for Depression in Spain (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top